Biogen Aktie
222,40 EUR +3,20 EUR +1,46 %
STU
239,29 USD ±0,00 USD ±0,00 %
nachbörslichNDB
NDB
Du hast schon ein Konto? Hier verknüpfen
Werbung
Biogen Rating
Biogen Inc Aktie Moody's Rating
Baa2
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Rating | Baa2 | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
Letzte Aktion | AFFIRM | Moody's Büro in | - |
Watchlist Datum | - | Watchlist | - |
Moody's Ratings Peer Group
Aktie | Rating |
---|---|
Amgen Inc. | Baa1 |
Bayer | Baa2 |
Gilead Sciences Inc. | A3 |